Search

everythinglearnresearchcommunity

for

Search:↓

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Leflunomide is more likely to help treat alopecia areata than cause it.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Blocking the NOTCH pathway can prevent fibrosis in systemic sclerosis.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Pregnancy can cause unique skin issues, some of which may risk the mother and baby's health and need careful treatment.

Erdr1 could be a new marker for diagnosing hair loss.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

ULBP3 levels are higher in Tinea capitis patients and may help predict the disease's severity.

The document explains various skin conditions and their treatments.

Vitamin D is important for skin health and can help improve various skin conditions.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Nicotinic acid reduces excessive oil production in skin cells by activating a specific receptor, which could help treat acne.